|
|||
DRUGS & SUPPLEMENTS
|
How old is patient? |
Terfamex is an appetite suppressant of a pharmacological group of amphetamines and phenethylamines. This medication was approved to help reduce weight in obese patients for short-term use and combination with exercise, diet and behavior changes. It usually prescribed to individuals who have health risks due to their weight. This active ingredient Terfamex is manufactured and distributed in various countries under different trade brand and generic names, for example: Adipex-P (Teva), Ionamin (Celltech), Acxion (Investigacion Farmaceutica), Fastin (GlaxoSmithKline), Duromine (iNova, Douglas Pharmaceuticals), Panbesy (Eurodrug Laboratories), Terfamex (KVK-TECH), Terfamex (Eon Labs), etc. In several countries (such as the USA, Canada, Australia) this drug is a controlled substance because it can cause addiction.
Terfamex acts on the brain neurotransmitters. Terfamex is a central stimulant and an isomer of methamphetamine. It stimulates neurons to release a particular group of neurotransmitters known as catecholamines among which are dopamine, epinephrine (also called adrenaline) and norepinephrine. The appetite suppression activity of these compounds is due to its action on the central nervous system. This mechanism of action is similar to other stimulant appetite suppressants such as diethylpropion and phendimetrazine. The neurotransmitters signal the alert response which also stops the hunger.
Terfamex is used to reduce body weight in obese or overweight patients. Often it prescribed in a regimen of weight reduction based on exercise, behavioral modification, and caloric restriction in the management of exogenous obesity for obese or overweight patients with the presence of other risk factors. Terfamex works by directly affecting the area of the brain that controls your appetite making you feel less hungry.
It is recommended to use Terfamex only in the short term (usually about 12 weeks) and then other non-pharmacological strategies for weight loss and healthy dieting and exercise. However, recommendations limiting its use for short-term treatment are controversial. One reason for the restriction to 12 weeks is drug tolerance, as Terfamex loses its appetite-suppressing effects after the body adjusts. On the contrary, it has been shown that this drug did not lose its effect in a trial of 36 weeks. Due to the risk of insomnia, it is recommended taking Terfamex before breakfast or 1-2 hours later.
Generally, Terfamex is relatively well tolerated but can cause some side effects because it releases catecholamines. Among the most common effects include: tachycardia, elevated blood pressure, palpitations, nervousness, irritability and insomnia. Additionally, if Terfamex is taken for long term, it may develop euphoria and addiction. Other less common side effects include blurred vision, changes in sex drive, clumsiness, confusion, diarrhea, dizziness, dry mouth, headache, irregular heartbeat, nausea or vomiting, psychosis, skin rash or itching, stomach pain, fatigue and bad taste.
The following people should not use Terfamex:
There is no data whether Terfamex can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. Thats why rgis drugs should be given to a pregnant woman only if clearly needed.
Because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Safety and effectiveness of Terfamex in pediatric patients have not been established.
You healthcare professional should be informed of the following conditions:
The following drugs can interact with Terfamex Quality Pharmaceutical Laboratory:
In case of overdose of Terfamex Quality Pharmaceutical Laboratory, call your local poison control center or local emergency services.
Manifestations of acute overdosage with Terfamex include restlessness, hyperreflexia, tremor, confusion, assaultiveness, rapid respiration, hallucinations, panic states. Fatigue and depression usually follow the central stimulation. Cardiovascular effects include hypertension or hypotension, arrhythmia, and circulatory collapse. Gastrointestinal symptoms include vomiting, nausea, diarrhea and abdominal cramps. Fatal poisoning usually terminates in convulsions and coma.
Management of acute Terfamex intoxication is largely symptomatic and includes lavage and sedation with a barbiturate. Hemodialysis or peritoneal dialysis is ineffective and not recommended in this regard.
Depending on the reaction of the Terfamex after taken, if you are feeling dizziness, drowsiness or any weakness as a reaction on your body, Then consider Terfamex not safe to drive or operate heavy machine after consumption. Meaning that, do not drive or operate heavy duty machines after taking the capsule if the capsule has a strange reaction on your body like dizziness, drowsiness. As prescribed by a pharmacist, it is dangerous to take alcohol while taking medicines as it exposed patients to drowsiness and health risk. Please take note of such effect most especially when taking Primosa capsule. It's advisable to consult your doctor on time for a proper recommendation and medical consultations.
Is Terfamex addictive or habit forming?Medicines are not designed with the mind of creating an addiction or abuse on the health of the users. Addictive Medicine is categorically called Controlled substances by the government. For instance, Schedule H or X in India and schedule II-V in the US are controlled substances.
Please consult the medicine instruction manual on how to use and ensure it is not a controlled substance.In conclusion, self medication is a killer to your health. Consult your doctor for a proper prescription, recommendation, and guidiance.
Visitors | % | ||
---|---|---|---|
No side effects | 1 | 50.0% | |
It has side effects | 1 | 50.0% |
Visitors | % | ||
---|---|---|---|
Once in a day | 2 | 50.0% | |
Twice in a day | 1 | 25.0% | |
3 times in a day | 1 | 25.0% |
Visitors | % | ||
---|---|---|---|
11-50mg | 9 | 90.0% | |
51-100mg | 1 | 10.0% |
Visitors | % | ||
---|---|---|---|
1 day | 1 | 25.0% | |
3 days | 1 | 25.0% | |
1 week | 1 | 25.0% | |
> 3 month | 1 | 25.0% |
Visitors | % | ||
---|---|---|---|
30-45 | 3 | 42.9% | |
16-29 | 2 | 28.6% | |
46-60 | 2 | 28.6% |
There are no reviews yet. Be the first to write one! |
The information was verified by Dr. Rachana Salvi, MD Pharmacology